Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 127Precursor Cell Lymphoblastic Leukemia-Lymphoma 46Burkitt Lymphoma 26Myelodysplastic Syndromes 25Leukemia 25Leukemia, Biphenotypic, Acute 21Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 15Lymphoma, Mantle-Cell 14Recurrence 13Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 10Myeloproliferative Disorders 9Lymphoma 9Lymphoma, Non-Hodgkin 8Leukemia, Myelomonocytic, Chronic 8Lymphoma, Large B-Cell, Diffuse 7Down Syndrome 6Neoplasm, Residual 5Hodgkin Disease 5Blast Crisis 5Sarcoma, Myeloid 4Lymphoma, T-Cell 4Leukemia, Monocytic, Acute 4Hematologic Neoplasms 4Lymphoma, Follicular 3Leukemia, Myelomonocytic, Juvenile 3Leukemia, Myelomonocytic, Acute 3Leukemia, Myeloid, Accelerated Phase 3Neoplasms 2Multiple Myeloma 2Lymphoma, B-Cell 2

Interventions

Methylprednisolone 3Social Determinants of Health 2trastuzumab deruxtecan 1sacituzumab govitecan 1pegaspargase 1Vincristine 1Temozolomide 1Radiotherapy 1Prednisone 1Prednisolone 1Pharmaceutical Services 1Methylprednisolone Hemisuccinate 1Methotrexate 1Mercaptopurine 1Leucovorin 1Irinotecan 1Infliximab 1Hydrocortisone 1Fecal Microbiota Transplantation 1Etoposide 1Drug Therapy 1Doxorubicin 1Dexrazoxane 1Dexamethasone 1Cytarabine 1Cyclophosphamide 1Cefixime 1CTLA-4 Antigen 1Asparaginase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × Cytarabine × 1 year × Clear all
NCT00400946 2026-02-13

05-001: Treatment of Acute Lymphoblastic Leukemia in Children

Dana-Farber Cancer Institute

Phase 3 Completed
800 enrolled 22 charts
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡